These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15860042)

  • 41. Role of oxidative stress in the natriuresis induced by central administration of angiotensin II.
    Israel A; Arzola J; De Jesús S; Varela M
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):9-14. PubMed ID: 19286753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.
    Kuroda J; Nakagawa K; Yamasaki T; Nakamura K; Takeya R; Kuribayashi F; Imajoh-Ohmi S; Igarashi K; Shibata Y; Sueishi K; Sumimoto H
    Genes Cells; 2005 Dec; 10(12):1139-51. PubMed ID: 16324151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism.
    Nascimento-Silva V; Arruda MA; Barja-Fidalgo C; Fierro IM
    Thromb Haemost; 2007 Jan; 97(1):88-98. PubMed ID: 17200775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-beta1-42.
    Zhou J; Zhang S; Zhao X; Wei T
    J Pineal Res; 2008 Sep; 45(2):157-65. PubMed ID: 18298462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease.
    Zafari AM; Davidoff MN; Austin H; Valppu L; Cotsonis G; Lassègue B; Griendling KK
    Antioxid Redox Signal; 2002 Aug; 4(4):675-80. PubMed ID: 12230880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease.
    Stanger O; Renner W; Khoschsorur G; Rigler B; Wascher TC
    Clin Physiol; 2001 Nov; 21(6):718-22. PubMed ID: 11722480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension.
    Zalba G; San José G; Moreno MU; Fortuño A; Díez J
    Antioxid Redox Signal; 2005; 7(9-10):1327-36. PubMed ID: 16115038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase.
    Laplante MA; de Champlain J
    Can J Physiol Pharmacol; 2006 Jan; 84(1):21-8. PubMed ID: 16845887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative enzymopathies and vascular disease.
    Leopold JA; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1332-40. PubMed ID: 15790928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease.
    Inoue N; Kawashima S; Kanazawa K; Yamada S; Akita H; Yokoyama M
    Circulation; 1998 Jan; 97(2):135-7. PubMed ID: 9445163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes.
    Hodgkinson AD; Millward BA; Demaine AG
    Diabetes Care; 2003 Nov; 26(11):3111-5. PubMed ID: 14578247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular C-reactive protein in the pathogenesis of coronary artery disease: role of vascular inflammation and oxidative stress.
    Inoue N
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):227-31. PubMed ID: 17378768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Progress in the studies on the relationship between the polymorphism of P22phox gene and coronary heart disease].
    Zhao JG; Gu DF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):105-8, 104. PubMed ID: 12905852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of oxidative stress in atherosclerosis.
    Harrison D; Griendling KK; Landmesser U; Hornig B; Drexler H
    Am J Cardiol; 2003 Feb; 91(3A):7A-11A. PubMed ID: 12645638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis.
    Di Castelnuovo A; Soccio M; Iacoviello L; Evangelista V; Consoli A; Vanuzzo D; Diviacco S; Carluccio M; Rignanese L; De Caterina R
    Thromb Haemost; 2008 Mar; 99(3):594-601. PubMed ID: 18327409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative stress and atherosclerosis.
    Singh U; Jialal I
    Pathophysiology; 2006 Aug; 13(3):129-42. PubMed ID: 16757157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension.
    Rafiq A; Aslam K; Malik R; Afroze D
    Mol Med Rep; 2014 May; 9(5):1857-62. PubMed ID: 24573492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypercholesterolaemia and vascular function: is the p22phox gene the missing link?
    Munroe PB;
    Clin Sci (Lond); 2003 Jul; 105(1):11-2. PubMed ID: 12683949
    [No Abstract]   [Full Text] [Related]  

  • 59. Vascular sources of oxidative stress: implications for uremia-related cardiovascular disease.
    Zanetti M; Barazzoni R; Bosutti A; Stocca A; Grassi G; Guarnieri G
    J Ren Nutr; 2007 Jan; 17(1):53-6. PubMed ID: 17198933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic markers of oxidative stress and coronary atherosclerosis.
    Madamanchi NR; Tchivilev I; Runge M
    Curr Atheroscler Rep; 2006 May; 8(3):177-83. PubMed ID: 16640954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.